T-PORT
Dead / Abandoned — Abandoned — failure to respond (as of 12 Aug 2024)
What this means for you
This application is over — abandoned 30 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79343431
- Mark type
- Stylized text
- Filed
- 25 May 2022
- Abandoned
- 30 Jul 2024
- Attorney of record
- Alexander Lazouski
Goods and services
- Class 010 — Medical apparatus: Apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; valves for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; implantable apparatus in the nature of implantable access device for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract
Owner
- Transcutan AB, SE
Prosecution history
- 07 Oct 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 Aug 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Aug 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Aug 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 12 Aug 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 12 Aug 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 29 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Jan 2024 — NON-FINAL ACTION E-MAILED
- 29 Jan 2024 — NON-FINAL ACTION WRITTEN
- 18 Dec 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 29 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 09 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED